benzyl [(2R)-1-(dimethylamino)-1-oxopropan-2-yl]carbamate | 486414-33-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: benzyl [(2R)-1-(dimethylamino)-1-oxopropan-2-yl]carbamate
• 英文别名: (1R-dimethylcarbamoyl-ethyl)-carbamic acid benzyl ester；N-benzyloxycarbonyl-D-alanine dimethylamide；benzyl N-[(2R)-1-(dimethylamino)-1-oxopropan-2-yl]carbamate
• CAS: 486414-33-9
• 化学式: C₁₃H₁₈N₂O₃
• 分子量: 250.298
• InChiKey: FABGDABUBWEOOQ-SNVBAGLBSA-N

物化性质

• 沸点：
  410.8±38.0 °C(Predicted)
• 密度：
  1.128±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  58.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  benzyl [(2R)-1-(dimethylamino)-1-oxopropan-2-yl]carbamate 在 palladium 10% on activated carbon 氢气 作用下， 以 乙醇 为溶剂， 以100%的产率得到(R)-2-氨基-N,N-二甲基-丙酰胺
  参考文献：
  名称：

  [EN] ANTIPROLIFERATIVE 2-(HETEROARYL)-AMINOTHIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE
  [FR] COMPOSES 2-(HETEROARYL)-AMINOTHIAZOLE ANTIPROLIFERATIFS, COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION

  摘要：

  由式（I）表示的化合物已被描述。这些化合物及含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病，以及/或在治疗或预防细胞增殖性疾病方面。

  公开号：

  WO2004014904A1
• 作为产物：
  描述：

  在 三氟乙酸 作用下， 以 水 为溶剂， 反应 24.0h， 以73%的产率得到benzyl [(2R)-1-(dimethylamino)-1-oxopropan-2-yl]carbamate
  参考文献：
  名称：

  CamTHP*OH:  A Camphor-Derived δ-Lactol Auxiliary for the Effective Desymmetrization of Attached Glycinamide Residues. Asymmetric Synthesis of α-Amino Carbonyl Compounds

  摘要：

  Stereoselective allylation of camphor and subsequent terminal hydroformylation affords a new delta-lactol auxiliary (camTHP*OH) on multigram scale. Stereoselective condensation with glycine dimethylamide and Cbz protection affords a camTHP*-desymmetrized glycinamide building block which undergoes efficient and highly diastereoselective metal enolate alkylation reactions. Acid-mediated deprotection affords the N-Cbz-protected a-amino amide products which may be converted directly to alpha-amino ketones on treatment with Grignard or organolithium reagents without loss of stereochemical integrity.

  DOI：

  10.1021/ol048569i

文献信息

• [EN] NITROGEN-CONTAINING HETEROCYCLIC COMPOUND<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE CONTENANT DE L'AZOTE
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2013018929A1

  公开（公告）日：2013-02-07

  The present invention provides a novel compound having a superior activity as an ERR-α modulator and useful as an agent for the prophylaxis or treatment of ERR-α associated diseases. The present invention relates to a compound represented by the formula (1) wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种新型的化合物，作为一种ERR-α调节剂具有优越的活性，并可作为预防或治疗与ERR-α相关疾病的药物。本发明涉及一种由公式(1)表示的化合物，其中每个符号如说明书中所定义，或其盐。
• Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
  申请人：——

  公开号：US20030225147A1

  公开（公告）日：2003-12-04

  Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. 1 These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.

  氨基噻唑化合物与单取代/双取代苯甲酰胺的结构由式(I)表示，并描述了它们的药学上可接受的盐、药学上可接受的前药、药学上活性代谢物以及所述代谢物的药学上可接受的盐。 这些药物调节和/或抑制细胞增殖和蛋白激酶活性，并可用作治疗恶性肿瘤和其他疾病的药物。
• Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and methods for their use
  申请人：Chong Kwan Mung Wesley

  公开号：US20050038078A1

  公开（公告）日：2005-02-17

  Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

  由化学式(I)代表的化合物被描述。这些化合物和含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病，以及/或在治疗或预防细胞增殖性疾病方面。
• Process and chiral amine intermediates useful for preparation of antiproliferative 2,4-diaminothiazole amide compounds
  申请人：Kucera John David

  公开号：US20050026966A1

  公开（公告）日：2005-02-03

  This invention relates to a novel process for preparing D-alanine derivatives and bis-toluenesulfonic acid salts thereof useful as intermediates in the preparation of 2,4-diaminothiazole amide compounds and pharmaceutical compositions containing such compounds. The invention also relates to such compounds and compositions that demonstrate antiproliferative activity such as antitumor activity. These compounds and compositions are also useful for treating various diseases and disorders associated with uncontrolled or unwanted cell proliferation and for inhibiting protein kinases.

  本发明涉及一种新型的制备D-丙氨酸衍生物和双甲苯磺酸盐的方法，其可作为制备2,4-二氨基噻唑酰胺化合物和含有此类化合物的药物组合物的中间体。本发明还涉及这些化合物和组合物，它们具有抗增殖活性，如抗肿瘤活性。这些化合物和组合物还可用于治疗与未受控制或不需要的细胞增殖相关的各种疾病和障碍，并抑制蛋白激酶。
• Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use
  申请人：Chong Kwan Mung Wesley

  公开号：US20050176773A1

  公开（公告）日：2005-08-11

  Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

  描述了由公式（I）表示的化合物。这些化合物和含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病以及/或治疗或预防细胞增殖性疾病方面使用。